BI Asset Management Fondsmaeglerselskab A/S
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1778131
KOBENHAVN, G7
Position in ALNY
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$1,884,966
-$4,027,691 QoQ
Shares Held
5,697
-61.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BI Asset Management Fondsmaeglerselskab A/S holds $81,144,167 across 10 Biotechnology names. ALNY ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,531 | $22,117,572 | |
| 2 | TECH |
BIO-TECHNE Corp
|
316,510 | $16,540,812 | |
| 3 | INCY |
Incyte Corp
|
155,246 | $14,611,753 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
148,752 | $9,613,841 | |
| 5 | EXEL |
Exelixis, Inc.
|
152,320 | $6,533,004 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
81,878 | $5,578,348 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,239 | $2,502,580 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
5,697 | $1,884,966 |
All Filings in ALNY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,884,966 | 5,697 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $5,912,657 | 14,869 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,057,480 | 6,705 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,253,934 | 6,912 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,442,446 | 5,342 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,766,069 | 11,755 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,344,080 | 8,523 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,108,566 | 4,562 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $556,551 | 3,724 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $721,424 | 3,769 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $299,830 | 1,693 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $419,577 | 2,209 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,416,259 | 12,062 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,337,969 | 5,630 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $582,265 | 2,909 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $456,510 | 3,130 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $305,025 | 1,868 | Shares | Defined | 2022-05-11 | |
| 2020-09-30 | $42,660 | 293 | Shares | Defined | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||